课题基金 / 基金详情

Characterization of stromal and innate lymphoid cell populations involved in immunotherapy resistance in High-Grade Serous Ovarian Cancer through multiOMICS analysis (CHRYSALIS)

Characterization of stromal and innate lymphoid cell populations involved in immunotherapy resistance in High-Grade Serous Ovarian Cancer through multiOMICS analysis (CHRYSALIS)
通过多组学分析 (CHRYSALIS) 表征参与高级别浆液性卵巢癌免疫治疗耐药性的基质细胞和先天淋巴细胞群
批准号：
459818
负责人：
Ohashi Pamela S
金额：
$22.87万
依托单位：
Princess Margaret Cancer Centre (Toronto)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-12-01 至 2024-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=459818&lang=en
关键词：
Artificial Intelligence Cancer Associated Fibroblasts Cytof High-Grade Serous Carcinoma Immune Function Immune Modulation Immunotherapy Innate Lymphoctyes Scatacseq Scrnaseq

项目摘要

项目成果

Ohashi Pamela S的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The immune system normally keeps our body healthy by fighting off viruses and bacteria that cause illnesses. Immunotherapy is a type of cancer treatment that increases the ability of the immune system to destroy tumor cells and has transformed the treatme
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Uncovering T cell trajectories in human cancer
Control of T cell - innate lymphoid cell crosstalk by B7-H3
Canada Research Chair Tier 1
  • 批准号：
    332856
  • 项目类别：
  • 资助金额：
    $101.99万
  • 财政年份：
    2014
  • 负责人：
    Ohashi Pamela S
  • 依托单位：
    University of Toronto
Regulating CD8 immunity and tumor immunity
  • 批准号：
    312874
  • 项目类别：
    Operating Grants
  • 资助金额：
    $204.51万
  • 财政年份：
    2014
  • 负责人：
    Ohashi Pamela S
  • 依托单位：
    University Health Network (Toronto)
海外基金